1. Stocks
  2. Telomir Pharmaceuticals Inc
  3. Swot
swot-logo

Telomir Pharmaceuticals Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Telomir Pharmaceuticals Inc has 7 Strengths, 9 Weaknesses, 4 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Rising Momentum: Momentum Score Weekly Gainers

Relative Outperformance versus Industry over 1 Week

Significant (over 30%) distance from 52 week high

Relative Outperformance versus Industry over 1 Month

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Month

Stock with Low PE (PE < = 10)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Highest fall from 52 Week High

Top Losers

Low Piotroski Score : Companies with weak financials

Annual net profit declining for last 2 years

Weak Momentum: Price below Short, Medium and Long Term Averages

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Forecaster Consensus Estimates: Stocks with Strong Buy Calls from Analysts

Institutions increasing their shareholding

Mutual Funds Increased Shareholding over the Past Two Months

MFs increased their shareholding last quarter

Mutual Funds Decreased Shareholding in Past Month

Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks